Search - tctmd.com

Displaying 1 - 20 of 168

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments

Todd Neale

December 14, 2017

News Daily News

FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document

Yael L. Maxwell

December 06, 2017

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Daily News

FDA Approves EluNIR Drug-Eluting Stent

Michael O'Riordan

November 30, 2017

News Industry News

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

November 30, 2017

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

News Industry News

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

November 14, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

Presentation TCT 2017

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Presenter: Lee N. Benson, Megan Coylewright

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, Andrew Farb

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Presenter: Hiren Mistry, Michael A. Weber

October 31, 2017

Presentation TCT 2017

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

Presenter: Hiren Mistry, Michael A. Weber, Michael Böhm

October 31, 2017

Presentation TCT 2017

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

Presenter: David E. Kandzari, Jaime Raben, John C Laschinger

October 31, 2017

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2017

High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments

FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document

Baim Institute Names Dr. C. Michael Gibson As CEO

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

FDA Approves EluNIR Drug-Eluting Stent

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

More Support for TMVR After Failed Mitral Bioprostheses

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content